Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxidectin+Albendazole vs Albendazole in Trichuriasis
NCT04726969Phase 3Completed
- Start
- Jun 2021
- Primary completion
- Sep 2021
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of moxidectin in trichuriasis. Started Jun 2021; status: completed.
02
Drugs
moxidectin
03
Conditions
trichuriasis
Beyond the preview
Go deeper on NCT04726969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04726969.